{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:07:12Z","timestamp":1793830032256,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-026-03402-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:37:52Z","timestamp":1776663472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal monitoring of denosumab-associated bone changes by REMS in postmenopausal women with ER-positive breast cancer receiving aromatase inhibitors."],"prefix":"10.1007","volume":"38","author":[{"given":"Carla","family":"Caffarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosachiara","family":"Forcignan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gonnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","volume":"386","author":"M Gnant","year":"2015","unstructured":"Gnant M, Pfeiler G, Dubsky PC et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 386:433\u2013443. https:\/\/doi.org\/10.1016\/S0140-6736(15)60995-3","journal-title":"Lancet"},{"key":"3402_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/BMR-210012","volume":"35","author":"D Scaturro","year":"2022","unstructured":"Scaturro D, de Sire A, Terrana P et al (2022) Early Denosumab for the prevention of osteoporotic fractures in breast cancer women undergoing aromatase inhibitors: A case-control retrospective study. J Back Musculoskelet Rehabil 35:207\u2013212. https:\/\/doi.org\/10.3233\/BMR-210012","journal-title":"J Back Musculoskelet Rehabil"},{"key":"3402_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/14712598.2020.1814731","volume":"20","author":"E Dell\u2019Aquila","year":"2020","unstructured":"Dell\u2019Aquila E, Armento G, Iuliani M et al (2020) Denosumab for cancer-related bone loss. Expert Opin Biol Ther 20:1261\u20131274. https:\/\/doi.org\/10.1080\/14712598.2020.1814731","journal-title":"Expert Opin Biol Ther"},{"key":"3402_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.18.01160","volume":"37","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Lacchetti C, Anderson H et al (2019) Adjuvant Endocrine Therapy for Women With Hormone Receptor\u2013Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol 37:423\u2013438. https:\/\/doi.org\/10.1200\/JCO.18.01160","journal-title":"J Clin Oncol"},{"key":"3402_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/jc.2010-1679","volume":"96","author":"RJ Santen","year":"2011","unstructured":"Santen RJ (2011) Effect of Endocrine Therapies on Bone in Breast Cancer Patients. J Clin Endocrinol Metab 96:308\u2013319. https:\/\/doi.org\/10.1210\/jc.2010-1679","journal-title":"J Clin Endocrinol Metab"},{"key":"3402_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(11)70389-8","volume":"13","author":"AM Cheung","year":"2012","unstructured":"Cheung AM, Tile L, Cardew S et al (2012) Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol 13:275\u2013284. https:\/\/doi.org\/10.1016\/S1470-2045(11)70389-8","journal-title":"Lancet Oncol"},{"key":"3402_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","volume":"7","author":"P Hadji","year":"2017","unstructured":"Hadji P, Aapro MS, Body J-J et al (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. J Bone Oncol 7:1\u201312. https:\/\/doi.org\/10.1016\/j.jbo.2017.03.001","journal-title":"J Bone Oncol"},{"key":"3402_CR8","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1016\/j.clbc.2021.04.009","volume":"21","author":"CL Shapiro","year":"2021","unstructured":"Shapiro CL (2021) Bone-modifying Agents (BMAs) in Breast Cancer. Clin Breast Cancer 21:e618\u2013e630. https:\/\/doi.org\/10.1016\/j.clbc.2021.04.009","journal-title":"Clin Breast Cancer"},{"key":"3402_CR9","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/bjc.2014.5","volume":"110","author":"E Colzani","year":"2014","unstructured":"Colzani E, Johansson ALV, Liljegren A et al (2014) Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer 110:1378\u20131384. https:\/\/doi.org\/10.1038\/bjc.2014.5","journal-title":"Br J Cancer"},{"key":"3402_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00774-020-01138-6","volume":"39","author":"Y Ouchi","year":"2021","unstructured":"Ouchi Y, Nakatsukasa K, Sakaguchi K et al (2021) The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results. J Bone Min Metab 39:224\u2013229. https:\/\/doi.org\/10.1007\/s00774-020-01138-6","journal-title":"J Bone Min Metab"},{"key":"3402_CR11","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","volume":"26","author":"GK Ellis","year":"2008","unstructured":"Ellis GK, Bone HG, Chlebowski R et al (2008) Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer. J Clin Oncol 26:4875\u20134882. https:\/\/doi.org\/10.1200\/JCO.2008.16.3832","journal-title":"J Clin Oncol"},{"key":"3402_CR12","doi-asserted-by":"publisher","first-page":"100252","DOI":"10.1016\/j.jbo.2019.100252","volume":"18","author":"A Galvano","year":"2019","unstructured":"Galvano A, Scaturro D, Badalamenti G et al (2019) Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials. J Bone Oncol 18:100252. https:\/\/doi.org\/10.1016\/j.jbo.2019.100252","journal-title":"J Bone Oncol"},{"key":"3402_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11154-010-9154-0","volume":"11","author":"G Karaguzel","year":"2010","unstructured":"Karaguzel G, Holick MF (2010) Diagnosis and treatment of osteopenia. Rev Endocr Metab Disord 11:237\u2013251. https:\/\/doi.org\/10.1007\/s11154-010-9154-0","journal-title":"Rev Endocr Metab Disord"},{"key":"3402_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Professor Kanis","year":"1994","unstructured":"Professor Kanis JA, Melton LJ, Christiansen C et al (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137\u20131141. https:\/\/doi.org\/10.1002\/jbmr.5650090802","journal-title":"J Bone Miner Res"},{"key":"3402_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1530\/ERC-16-0025","volume":"23","author":"M Rodr\u00edguez-Sanz","year":"2016","unstructured":"Rodr\u00edguez-Sanz M, Prieto-Alhambra D, Servitja S et al (2016) AI-related BMD variation in actual practice conditions: A prospective cohort study. Endocr Relat Cancer 23:303\u2013312. https:\/\/doi.org\/10.1530\/ERC-16-0025","journal-title":"Endocr Relat Cancer"},{"key":"3402_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jocd.2020.10.013","volume":"24","author":"C Messina","year":"2021","unstructured":"Messina C, Acquasanta M, Rinaudo L et al (2021) Short-Term Precision Error of Bone Strain Index, a New DXA-Based Finite Element Analysis Software for Assessing Hip Strength. J Clin Densitometry 24:330\u2013337. https:\/\/doi.org\/10.1016\/j.jocd.2020.10.013","journal-title":"J Clin Densitometry"},{"key":"3402_CR17","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.crad.2013.03.028","volume":"68","author":"M Bandirali","year":"2013","unstructured":"Bandirali M, Messina C, Di Leo G et al (2013) Bone mineral density differences between femurs of scoliotic patients undergoing dual-energy X-ray absorptiometry. Clin Radiol 68:e511\u2013e515. https:\/\/doi.org\/10.1016\/j.crad.2013.03.028","journal-title":"Clin Radiol"},{"key":"3402_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.acra.2020.07.028","volume":"28","author":"D Albano","year":"2021","unstructured":"Albano D, Agnollitto PM, Petrini M et al (2021) Operator-Related Errors and Pitfalls in Dual Energy X-Ray Absorptiometry: How to Recognize and Avoid Them. Acad Radiol 28:1272\u20131286. https:\/\/doi.org\/10.1016\/j.acra.2020.07.028","journal-title":"Acad Radiol"},{"key":"3402_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-018-4686-3","volume":"30","author":"M Di Paola","year":"2019","unstructured":"Di Paola M, Gatti D, Viapiana O et al (2019) Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck. Osteoporos Int 30:391\u2013402. https:\/\/doi.org\/10.1007\/s00198-018-4686-3","journal-title":"Osteoporos Int"},{"key":"3402_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40520-019-01294-4","volume":"31","author":"A Diez-Perez","year":"2019","unstructured":"Diez-Perez A, Brandi ML, Al-Daghri N et al (2019) Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art\u2014outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res 31:1375\u20131389. https:\/\/doi.org\/10.1007\/s40520-019-01294-4","journal-title":"Aging Clin Exp Res"},{"key":"3402_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02358-2","author":"P Pisani","year":"2023","unstructured":"Pisani P, Conversano F, Muratore M et al (2023) Fragility Score: a REMS-based indicator for the prediction of incident fragility fractures at 5 years. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-023-02358-2","journal-title":"Aging Clin Exp Res"},{"key":"3402_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40520-023-02677-4","volume":"36","author":"R Ramirez Zegarra","year":"2024","unstructured":"Ramirez Zegarra R, Degennaro V, Brandi ML et al (2024) Longitudinal changes of the femoral bone mineral density from first to third trimester of pregnancy: bone health assessment by means of non-ionizing REMS technology. Aging Clin Exp Res 36:31. https:\/\/doi.org\/10.1007\/s40520-023-02677-4","journal-title":"Aging Clin Exp Res"},{"key":"3402_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/15409996251372853","volume":"34","author":"F Arechavaleta-Velasco","year":"2025","unstructured":"Arechavaleta-Velasco F, Diaz-Cueto L, Rosales-Ortiz S (2025) Maternal Bone Mineral Density Changes during Pregnancy: A Longitudinal Prospective Study Using Radiofrequency Echographic Multi-Spectrometry. J Womens Health 34:1365\u20131373. https:\/\/doi.org\/10.1177\/15409996251372853","journal-title":"J Womens Health"},{"key":"3402_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00223-024-01240-1","volume":"115","author":"A Al Refaie","year":"2024","unstructured":"Al Refaie A, Baldassini L, Mondillo C et al (2024) Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study. Calcif Tissue Int 115:160\u2013168. https:\/\/doi.org\/10.1007\/s00223-024-01240-1","journal-title":"Calcif Tissue Int"},{"key":"3402_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocd.2006.03.014","volume":"9","author":"A El Maghraoui","year":"2006","unstructured":"El Maghraoui A, Achemlal L, Bezza A (2006) Monitoring of Dual-Energy X-ray Absorptiometry Measurement in Clinical Practice. J Clin Densitometry 9:281\u2013286. https:\/\/doi.org\/10.1016\/j.jocd.2006.03.014","journal-title":"J Clin Densitometry"},{"key":"3402_CR26","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00330-014-3509-y","volume":"25","author":"C Messina","year":"2015","unstructured":"Messina C, Bandirali M, Sconfienza LM et al (2015) Prevalence and type of errors in dual-energy x-ray absorptiometry. Eur Radiol 25:1504\u20131511. https:\/\/doi.org\/10.1007\/s00330-014-3509-y","journal-title":"Eur Radiol"},{"key":"3402_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000337763","volume":"7","author":"DM Conde","year":"2012","unstructured":"Conde DM, Costa-Paiva L, Martinez EZ, Pinto-Neto AM (2012) Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors. Breast Care 7:121\u2013125. https:\/\/doi.org\/10.1159\/000337763","journal-title":"Breast Care"},{"key":"3402_CR28","doi-asserted-by":"publisher","first-page":"e1911080","DOI":"10.1001\/jamanetworkopen.2019.11080","volume":"2","author":"R Pedersini","year":"2019","unstructured":"Pedersini R, Amoroso V, Maffezzoni F et al (2019) Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy. JAMA Netw Open 2:e1911080. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.11080","journal-title":"JAMA Netw Open"},{"key":"3402_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11657-014-0175-2","volume":"9","author":"JT Lloyd","year":"2014","unstructured":"Lloyd JT, Alley DE, Hawkes WG et al (2014) Body mass index is positively associated with bone mineral density in US older adults. Arch Osteoporos 9:175. https:\/\/doi.org\/10.1007\/s11657-014-0175-2","journal-title":"Arch Osteoporos"},{"key":"3402_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00198-010-1305-3","volume":"22","author":"D Sukumar","year":"2011","unstructured":"Sukumar D, Schlussel Y, Riedt CS et al (2011) Obesity alters cortical and trabecular bone density and geometry in women. Osteoporos Int 22:635\u2013645. https:\/\/doi.org\/10.1007\/s00198-010-1305-3","journal-title":"Osteoporos Int"},{"key":"3402_CR31","doi-asserted-by":"publisher","first-page":"115786","DOI":"10.1016\/j.bone.2020.115786","volume":"143","author":"B Cortet","year":"2021","unstructured":"Cortet B, Dennison E, Diez-Perez A et al (2021) Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context. Bone 143:115786. https:\/\/doi.org\/10.1016\/j.bone.2020.115786","journal-title":"Bone"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-026-03402-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:55:32Z","timestamp":1780959332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-026-03402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1007\/s40520-026-03402-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9267684\/v1","asserted-by":"object"}]},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Review Board of the participating hospital, and it was conducted in accordance with the ethical standards of the Declaration of Helsinki (1964).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Informed consent for participation and publication has been obtained from all the participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"151"}}